0001683168-23-009152.txt : 20231229 0001683168-23-009152.hdr.sgml : 20231229 20231229172422 ACCESSION NUMBER: 0001683168-23-009152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DVONCH JEROME J CENTRAL INDEX KEY: 0001518735 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33216 FILM NUMBER: 231528671 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001367083 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 680423298 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 5445 CONESTOGA COURT, SUITE 150 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 800-759-9305 MAIL ADDRESS: STREET 1: 5445 CONESTOGA COURT, SUITE 150 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc. DATE OF NAME CHANGE: 20060622 4 1 ownership.xml X0508 4 2023-12-29 0 0001367083 Sonoma Pharmaceuticals, Inc. SNOA 0001518735 DVONCH JEROME J C/O SONOMA PHARMACEUTICALS, INC. 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 0 1 0 0 Interim CFO 0 Stock option (right to buy) 0.18 2023-12-29 4 A 0 60000 A 2033-12-29 Common Stock 60000 117777 D The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control. The options were awarded and granted to Mr. Dvonch for services performed as part of the Company's annual grant of stock options. /s/ Jerome Dvonch 2023-12-29